The company said that the claims allowed cover the use of some important gene sequences in blood sample for detection and monitoring of ...
You must be logged in to view the whole article.
Click here if you require signing up
Sanofi, Curie Institute join hands in research on ovarian cancer
Aurigene, Debiopharm nominate oncology development candidate Debio 0617B
Newron unveils promising Phase I/II safety, efficacy data for sNN0031 in Parkinson's disease
AMRI awarded DEA approval to handle Schedule 2 and 2N controlled substances at Burlington site
JDRF, Becton Dickinson extend collaboration in Type 1 diabetes
Nicox adds Immco Diagnostics' Sjogren's Syndrome test to portfolio
Newron, Zambon unveil positive Phase III data for safinamide in Parkinson's
Rockwell Medical awarded USD20m in debt financing by Hercules Technology Growth Capital
Takeda Pharmaceutical Company introduces NESINA, fixed-dose combinations KAZANO and OSENI in US
TWi Biotechnology complete patient enrolment for AC-201 phase II trial for gout flare prophylaxis
Teva Pharmaceutical Industries to acquire MicroDose Therapeutx
Medicago receives patent for influenza virus-like particles in plants
Laboratory Corporation of America Holdings provides Roche viral load assay for hepatitis C virus